Harpoon Therapeutics Inc (HARP) has released an update to notify the public and investors about corporate charter and bylaws modifications.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Harpoon Therapeutics, Inc. amended its Certificate of Designation for its 8.000% Series A Redeemable Preferred Stock to incorporate changes from a one-for-ten reverse stock split of its common stock that took place on September 1, 2023. This amendment was filed with the Secretary of State of Delaware on January 26, 2024.
For further insights into HARP corporate activity, check out TipRanks’ Insiders Trading Activity page.